Cash Flow from Investing Activities: The total change in cash resulting from a company's investments.
PURE Bioscience (PURE) Cash Flow from Investing Activities data is not available for the most recently reported fiscal quarter, ending 2025-04-30.
| Income Statement Financials | |
$0.49M |
|
$-0.58M |
|
$0.21M |
|
$0.28M |
|
$1.07M |
|
$-0.58M |
|
$0.00M |
|
$-0.58M |
|
$-0.58M |
|
$-0.58M |
|
$-0.58M |
|
$-0.58M |
|
$-0.58M |
|
$-0.58M |
|
$-0.58M |
|
111.86M |
|
111.86M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$1.05M |
|
$0.01M |
|
$0.01M |
|
$1.06M |
|
$0.97M |
|
$4.90M |
|
$4.90M |
|
$5.87M |
|
$-4.81M |
|
$-4.81M |
|
$-4.81M |
|
111.86M |
|
| Cash Flow Statement Financials | |
$-1.56M |
|
|
Cash Flow from Investing Activities |
-- |
$1.75M |
|
$0.42M |
|
$0.61M |
|
$0.19M |
|
$0.12M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.08 |
|
-- |
|
-- |
|
57.64 |
|
-1.02 |
|
57.64% |
|
-118.94% |
|
-118.94% |
|
-- |
|
-118.13% |
|
-118.13% |
|
$-1.56M |
|
-- |
|
-- |
|
-- |
|
0.46 |
|
1.59 |
|
1.71 |
|
52.61 |
|
12.05% |
|
12.05% |
|
-54.87% |
|
-682.35% |
|
$-0.04 |
|
$-0.01 |
|
$-0.01 |
|